WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02B VITAMIN K AND OTHER HEMOSTATICS

The DDDs are based on treatment of hemorrhage associated with different deficiency states (e.g. vitamin K deficiency, deficiency of different blood coagulation factors etc.).


B02BD Blood coagulation factors

This group comprises all blood coagulation factors, thrombin etc., incl. preparations for local use, and their combinations. Gene therapy products replacing coagulation factors are also classified in this group.
For systemic formulations of fibrinogen (factor I), see - B02BB - Fibrinogen.
Prothrombin complexes containg three or all four factors are classified in B02BD01 coagulation factor IX, II, VII and X.
Both human derived and recombinant factor VIII and factor IX products will be classified in B02BD02 - coagulation factor VIII and B02BD04 - coagulation factor IX, respectively.

No DDDs are established for blood coagulation factors. The use of blood coagulation factors could be measured in blood factor units (IU).


List of abbreviations

Last updated: 2024-01-26